Global Active Pharmaceutical Ingredients (API) Market

1. Global Active Pharmaceutical Ingredients (API) Market to Grow on the Back of Increasing Prevalence of Chronic Diseases Worldwide; Market to Grow with a CAGR of 6.08% During 2021- 2030 Kenneth Research has released a report titled “Active Pharmaceutical Ingredients (API) Market: Global Demand Analysis & Opportunity Outlook 2030” which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, along with the impact of COVID-19 and a detailed discussion on the latest trends and future opportunities that are associated with the growth of themarket. In one of the statistics by the World Health Organization (WHO),around 17.9 Million people in the year 2019, died from cardiovascular diseases (CVDs), while 1.5 Million deaths were caused due to diabetes in the same year. Moreover, in the year 2020, cancer accounted for around 10 Million deaths. Get a Sample Copy of this Report with Graphs and Charts: - https://www.kennethresearch.com/sample-request-10352347 The statistics portray the growing prevalence of different types of chronic diseases worldwide, which is driving the need amongst the pharmaceutical drug manufacturers for advanced drug ingredients which can help them in formulating drugs that can treat these diseases. Activepharmaceutical

2. ingredients (APIs) are an important componentinmodernday pharmaceutical drug manufacturing and are widely preferred by pharmaceutical drug manufacturers owing to the numerous benefits associated with these ingredients. Besides this, the surge in demand for generic and biosimilar drugs are also expected to create numerous growth opportunities for the growth of the global active pharmaceutical ingredients (API) market in the comingyears. The global active pharmaceutical ingredients (API) market is anticipated to grow with a CAGR of 6.08% over the forecast period, i.e., 2021 – 2030. The market is estimated to garner a revenue of USD 331.37 Billion by the end of 2030.Moreover,intheyear2020,themarketgeneratedarevenueofUSD 185.23 Billion. The market is segmented by therapeutic application into communicable disease, oncology, diabetes, cardiovascular disease, musculoskeletal disorders, respiratory disorders, andothertherapeutic applications. The cardiovascular disease segment, out of all the other segments, is anticipated to garner the largest revenue of USD 68.81 Billion bytheendof2030.Moreover,thesegmentgeneratedarevenueofUSD 39.50 Billion in the year2020. By region, the global active pharmaceutical ingredients (API) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America, out of the market in all the other regions, is anticipated to garner thelargestrevenueofUSD127.61Billionbytheendof2030.Additionally,

3. themarketintheregiongeneratedarevenueofUSD71.70Billionintheyear 2020. The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia,NewZealand,RestofAsia-Pacific),MiddleEastandAfrica(Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the researchreport. However, the high cost of manufacturing of APIs is one of the major factors predicted to hinder the market growth in the comingyears. Thisreportalsoprovidestheexistingcompetitivescenarioofsomeofthekey players of the global active pharmaceutical ingredients (API) market, which includescompanyprofilingofPfizerInc.,GlaxoSmithKlineplc,NovartisAG, Sanofi-aventis Groupe, Boehringer Ingelheim International GmbH, AurobindoPharma,Dr.Reddy’sLaboratoriesLtd.,APICorporation,Bristol- Myers Squibb Company, KATSURA CHEMICAL CO., LTD., andothers. The profiling enfolds key information of the companies which comprises of businessoverview,productsandservices,keyfinancialsandrecentnewsand

4. developments. Conclusively, the report titled “ActivePharmaceutical Ingredients (API) Market: OpportunityOutlook2030”, Global analyses industry DemandAnalysis& the overall global active pharmaceuticalingredients(API) tohelpnewentrantsto understand the details of the market. In addition to that, this report also guidesexistingplayerslookingforexpansionandmajorinvestorslookingfor investment in the global active pharmaceutical ingredients (API) market in the near future. Download Free Sample Reports Here - https://www.kennethresearch.com/sample-request-10352347 Kenneth Research is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment, etc. We believe every business can expand to its new horizon, providedarightguidanceatarighttimeisavailablethroughstrategicminds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties. Contact for moreInfo: AJDaniel Email: sales@kennethresearch.com U.S. Phone: +1 313 4620609